Rovi’s Value-Added US Risperidone Gets New Goal Date, Teva Ruled Out As Partner

Follows Teva’s Recent Launch Of Rovi’s Xeplion Generic In Spain

 
• By Dean Rudge
  
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Value Added Medicines

More from Products